Overview
Late infantile CACH syndrome (Childhood Ataxia with Central Nervous System Hypomyelination), also known as late infantile Vanishing White Matter disease (VWM), is a rare inherited leukoencephalopathy caused by mutations in genes encoding subunits of the eukaryotic translation initiation factor 2B (EIF2B1-EIF2B5). The late infantile form represents one of the more severe phenotypic variants of VWM disease, with onset typically occurring between ages 1 and 2 years. The disease primarily affects the central nervous system, specifically the white matter of the brain, which progressively deteriorates and is replaced by fluid-filled cavities — hence the name 'vanishing white matter.' Key clinical features of the late infantile form include progressive cerebellar ataxia (loss of coordination), spasticity, cognitive decline, and eventual loss of motor and intellectual abilities. A hallmark of VWM disease is that neurological deterioration can be triggered or dramatically worsened by episodes of physiological stress such as febrile infections, minor head trauma, or acute fright. Seizures may also occur. Brain MRI characteristically shows diffuse white matter abnormalities with progressive rarefaction and cystic degeneration. Ovarian failure (ovarioleukodystrophy) can be an associated feature in females, though this is more commonly noted in later-onset forms. There is currently no cure or disease-modifying treatment for late infantile CACH syndrome. Management is supportive and symptomatic, focusing on physical therapy, prevention and careful management of febrile episodes and infections, seizure control when needed, and nutritional support. Avoidance of physiological stressors that can precipitate neurological crises is a critical aspect of care. The prognosis for the late infantile form is generally poor, with progressive neurological decline leading to severe disability. Research into potential therapies, including gene therapy approaches, is ongoing.
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Infantile
Begins in infancy, roughly 1 month to 2 years old
Treatments
No FDA-approved treatments are currently listed for Late infantile CACH syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Late infantile CACH syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Late infantile CACH syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Late infantile CACH syndrome.
Community
No community posts yet. Be the first to share your experience with Late infantile CACH syndrome.
Start the conversation →Latest news about Late infantile CACH syndrome
No recent news articles for Late infantile CACH syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Late infantile CACH syndrome
What is Late infantile CACH syndrome?
Late infantile CACH syndrome (Childhood Ataxia with Central Nervous System Hypomyelination), also known as late infantile Vanishing White Matter disease (VWM), is a rare inherited leukoencephalopathy caused by mutations in genes encoding subunits of the eukaryotic translation initiation factor 2B (EIF2B1-EIF2B5). The late infantile form represents one of the more severe phenotypic variants of VWM disease, with onset typically occurring between ages 1 and 2 years. The disease primarily affects the central nervous system, specifically the white matter of the brain, which progressively deteriorat
How is Late infantile CACH syndrome inherited?
Late infantile CACH syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Late infantile CACH syndrome typically begin?
Typical onset of Late infantile CACH syndrome is infantile. Age of onset can vary across affected individuals.